A current perspective of the status of understanding BOLD imaging and its use in studying brain function: a summary of the workshop at the University of North Carolina in Chapel Hill, 26-28 October, 2000

Susceptibility-weighted imaging to visualize blood products and improve tumor contrast in the study of brain masses

PURPOSE

To evaluate the diagnostic value of susceptibility-weighted imaging (SWI) for studying brain masses.

MATERIALS AND METHODS

SWI is a high-resolution, three-dimensional, fully velocity-compensated gradient-echo sequence that uses both magnitude and phase data. Custom postprocessing is applied to enhance the contrast in the magnitude images between tissues with different susceptibilities. This sequence was applied to 44 patients (24 males and 20 females, 15-89 years old, mean age = 50.3 years) with brain masses, pre- and/or postcontrast, and compared with conventional sequences (T1, T1 postcontrast, T2, proton density (PD), fluid-attenuated inversion recovery (FLAIR) and diffusion-weighted imaging (DWI) at 1.5T). Correlation with pathology was obtained in 12 cases. All images were reviewed independently by three radiologists.

RESULTS

In the evaluation of tumor visibility, boundary definition, blood products, venous vasculature, architecture, and edema, SWI gave better information than the standard T1-weighted postcontrast images in 11%, 14%, 71%, 73%, 63%, and 75% of the data, respectively, in a subgroup of 38 patients. This demonstrates that the information presented by SWI is complementary in nature to that available from conventional methods. On the whole, SWI was much more sensitive for showing blood products and venous vasculature. SWI showed a useful FLAIR-like contrast and complemented the information obtained by conventional T1 postcontrast sequences regarding the internal architecture of the lesions. Good pathologic correlations were found for blood products as predicted by SWI.

CONCLUSION

SWI should prove useful for tumor characterization because of its ability to better highlight blood products and venous vasculature and reveal new internal architecture.

[Susceptibility weighted imaging. Theory and applications]

Susceptibility Weighted Imaging (SWI) is a new MR imaging technique using the BOLD effect (Blood Oxygen Level Dependent) and the differences of susceptibility between tissues. It is a 3D gradient echo, fully velocity compensated sequence. The echo time is chosen to maximize the signal cancellation in veins and a specific post-processing is applied using the phase images as a complementary source of contrast. It is very useful for the visualization of veins either normal or abnormal. It shows hemorrhage, even of small quantity, better than conventional gradient echo sequences. Its use is still limited by a long acquisition time and some remaining artifacts.